{
  "paper_metadata": {
    "pmid": "28951660",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 29,
        "demographics": "Patients included 18 with wild-type TTR and 11 with Val122Ile variant; demographics not specified further.",
        "phenotype": "Transthyretin cardiomyopathy (TTR-CM)"
      },
      "penetrance_data": {
        "total_carriers_observed": 15,
        "affected_count": 12,
        "unaffected_count": 3,
        "uncertain_count": null,
        "penetrance_percentage": 80.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "TTR-CM with symptoms",
          "evidence_sentence": "During the TRACS study, there were 12 patient deaths (Val122Ile: n\u2009=\u20098; wild-type: n\u2009=\u20094)."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "TTR-CM with symptoms",
          "evidence_sentence": "During the TRACS study, there were 12 patient deaths (Val122Ile: n\u2009=\u20098; wild-type: n\u2009=\u20094)."
        },
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms reported",
          "evidence_sentence": "During the TRACS study, there were 12 patient deaths (Val122Ile: n\u2009=\u20098; wild-type: n\u2009=\u20094)."
        }
      ],
      "functional_data": {
        "summary": "Tafamidis treatment showed significant survival benefit in patients with TTR-CM.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "3% to 4% in African Americans or people of African descent.",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study included both treated and untreated patients.",
      "key_quotes": [
        "Patients with either wild-type or Val122Ile genotypes treated with tafamidis have a significantly longer time to death compared with untreated patients."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted from the main text and included individual-level penetrance data."
  }
}